throbber
COMPARATIVE STUDIES ON ADRENAL CORTICAL FUNCTION
`AND CORTISOL METABOLISM IN HEALTHY ADULTS AND
`IN PATIENTS WITH SHOCK DUE TO INFECTION
`
`BY JAMES C. MELBY AND WESLEY W. SPINK
`
`(From the University of Minnesota Medical School, Minneapolis, Minn.)
`
`(Submitted for publication April 28, 1958; accepted August 28, 1958)
`
`the adrenal glands has
`Secretory failure of
`continued to be implicated as a factor in the patho-
`genesis of peripheral circulatory collapse due to
`infection since the original
`reports of Water-
`house (1) and of Friderichsen (2). This as-
`sociation of adrenal function and circulatory fail-
`ure has been cited in recent reviews (3-5). How-
`ever, a deficit of adrenal secretory products or
`their urinary metabolites in peripheral collapse
`due to infection has not been reported.
`Investiga-
`tions in our laboratory have shown that shock
`produced in dogs by endotoxins of gram—nega-
`tive bacteria was accompanied by an elevation of
`the concentration of cortisol
`in the plasma, and
`the output of cortisol
`in adrenal venous blood
`rose abruptly immediately after the injection of
`endotoxin (6).
`This report is concerned with the assessment of
`adrenal cortical function in human patients having
`peripheral circulatory failure due to severe in-
`fections.
`Studies with a 21—hemisuccinate ester
`
`of cortisol, which is rapidly hydrolyzed to free
`cortisol in viva, were undertaken in order to de-
`lineate the metabolism of cortisol,
`the principal
`adrenal secretory product in man (7).
`
`M ETH ODS
`
`The subjects in this study included 9 healthy adults and
`22 patients with severe infections complicated by circu-
`latory collapse. Fifteen of these patients had demonstra-
`ble bacteremia at the time the studies were carried out.
`All of the patients were hypotensive with systolic blood
`pressures under 90 mm. of Hg. A summary of the clini-
`cal data on these patients is recorded in Table I.
`Blood samples for the determination of cortisol con-
`centrations in the plasma were analyzed by a modification
`of the method of Silber and Porter (8) as described by
`Peterson, Karrer and Guerra (9). This method is spe-
`cific for steroids with the 17,21-dihydroxy-20-keto con-
`figuration including cortisol, cortisone, Compound S and
`their dihydro- and tetrahydro- derivatives. Of these, only
`cortisol exists in the plasma in significant concentrations;
`therefore, the method may be regarded as highly specific
`for cortisol.
`
`in eight normal
`Adrenal stimulation was carried out
`subjects and in six patients with shock due to infection
`by an intravenous infusion of 25 U.S.P. units of corti-
`cotropin (Upjohn, Sterile Corticotropin Injection) dis-
`solved in 500 ml. of 5 per cent dextrose in water, which
`was given over a period of four hours. Specimens of 15
`ml. of heparinized blood were secured initially and at the
`conclusion of the infusion of corticotropin. The erythro-
`cytes were separated from the plasma within 30 minutes.
`The samples were frozen and plasma cortisol
`levels
`were determined within 72 hours.
`In order to determine the rate of disappearance of
`exogenous cortisol, an intravenous injection of 100 mg. of
`cortisol sodium succinate dissolved in 2 ml. of distilled
`water (Upjohn, Hydrocortisone Sodium Succinate) was
`given to each of 9 normal subjects and to 20 patients with
`shock. Samples of blood were obtained immediately pre-
`ceding the injection of cortisol sodium succinate and at
`30, 90, 150, 210 and 270 minutes thereafter in the patients
`with shock. The blood specimens were treated as above.
`The sodium succinate ester of cortisol was employed be-
`cause it is highly soluble and because it can be adminis-
`tered in a small volume of aqueous diluent in a few sec-
`onds. Hydrolysis of
`the ester
`is
`rapid and complete
`within 15 minutes after injection. The ester is not ex-
`tracted from plasma by methylene chloride which is
`employed as the solvent in the determination of plasma
`cortisol (10). The rate of removal of cortisol from the
`plasma of pregnant women was determined after
`the
`rapid infusion of cortisol sodium succinate by Christy,
`Gordon, Longson, Wallace and Jailer
`(11). The dis-
`posal of
`this cortisol ester did not significantly differ
`from cortisol removal rates following infusions of corti-
`sol free alcohol. Madsen, Done, Ely and Kelley (12)
`found no significant differences in the plasma half—time
`of cortisol whether administered as the free alcohol or
`the 21-hemisuccinate ester.
`In patients with shock these procedures were carried
`out within a few hours after the recognition of peripheral
`circulatory failure.
`
`RESULTS
`
`A. Relationship of the clinical status to the out-
`come
`
`The data recorded in Table I reveal that demon-
`strable bacteremia was associated with shock in
`
`70 per cent of the cases. Gram-negative bacteria
`
`1791
`
`Amerigen Exhibit 1163
`Amerigen Exhibit 1163
`Amerigen v. Janssen IPR2016-00286
`Amerigen V. Janssen IPR2016-00286
`
`

`
`JAMES C. MELBY AND WESLEY W. SPINK
`
`TABLE I
`
`Clinical data on 22 patients with peripheral circulatory failure due to infection
`
`Diagnosis
`
`Bacteriology
`
`Source of
`bacteria
`
`Blood
`DIESSIIYC
`
`Duration
`of hypo-
`tension
`
`Temp.
`in F.
`
`Skin
`appearance
`
`Lobar pneumonia
`
`D. pneumo-
`coccus
`
`Sputum
`
`80/55
`
`Diabetes, urinary
`tract infection
`
`Prostatic hypertrophy,
`cystoscopy
`
`Postoperative
`ovarian cystectomy
`
`Urethral stricture,
`cystoscopy
`
`Pseudomembranous
`enteritis
`
`E. coli
`
`E. ooh’
`
`E. colt"
`
`Proteus
`
`Staph.
`
`Blood
`Urine
`
`Blood
`Urine
`
`Urine
`
`Blood
`Urine
`
`Feces
`Blood
`
`60/30
`
`84/50
`
`50/30
`
`72/50
`
`64/36
`
`24 hrs.
`
`105.0
`
`24 hrs.
`
`103.0
`
`16 hrs.
`
`104.4
`
`24 hrs.
`
`105.0
`
`12 hrs.
`
`103.2
`
`Warm,
`suffused
`
`Warm,
`suflused
`
`Warm,
`suffused
`
`Warm,
`suffused
`
`Warm,
`sufiused
`
`Outcome
`
`Recovered
`
`Recovered
`
`Recovered
`
`Recovered
`
`Recovered
`
`M. tuberculosis
`
`24 hrs.
`
`36 hrs.
`
`104.0
`
`Cold, moist
`
`Recovered
`
`Recovered
`
`Recovered
`
`Died
`
`Died
`
`Miliary tuberculosis
`
`Sputum
`
`74/44
`
`104.0
`
`24 hrs.
`
`102.2
`
`Warm,
`suffused
`
`Warm,
`suffused
`
`TUR, metastases from
`cancer of renal pelvis
`
`E. coli
`
`. Osteomyelitis,
`pyelonephritis
`
`Chronic lymphatic
`leukemia, peritonitis,
`cirrhosis
`
`Peritoneal abscess,
`metastatic adeno-
`carcinoma of colon
`
`Massive pneumonia,
`renal abscess
`
`Cancer of prostate,
`pneumonia
`
`Perforated ulcer
`with peritonitis
`
`Postoperative bowel
`obstruction, staph.
`septicemia with
`metastatic abscesses
`
`Pyelonephritis,
`cholangitis,
`purpura, hepatic
`abscesses
`
`Suppurative
`peritonitis,
`postoperative
`gastrectomy
`
`Pulmonary emboli
`
`Total gastrectomy for
`cancer of stomach,
`post-gastrectomy
`
`Staph.
`
`Staph .
`
`Proteus
`E. coli
`
`Staph.
`
`Pseudomonas
`E. coli
`
`Pseudomonas
`
`E. ooh’
`Strep. viridans
`Proteus
`Staph.
`Pseudomonas
`
`30/50
`
`86/56
`
`50/0
`
`Blood
`Urine
`
`Blood
`Wound
`
`Blood
`Peri-
`toneal
`fluid
`
`Blood
`
`Blood
`Sputum
`
`Sputum
`Urine
`
`Peri-
`toneal
`fluid
`
`Blood
`Urine
`
`Blood
`Peri-
`toneal
`fluid
`
`Urine
`Blood
`
`Sub-
`phrenic
`abscess
`Empyema.
`
`80/50
`
`80/0
`
`2 wks.
`
`104.0
`
`Cold, moist
`
`48 hrs.
`
`101.0
`
`Cold, moist
`
`Cold, moist
`
`Cold, moist
`
`Cold, moist
`
`Cold,
`cyanotic
`
`Cold,
`cyanotic
`
`Cold, moist
`
`Cold, moist
`
`

`
`ADRENAL FUNCTION IN SHOCK DUE TO INFECTION
`
`TABLE I—Cant1'nued
`
`Diagnosis
`
`Bacteriology
`
`Source of
`bacteria
`
`Blood
`pressure
`
`Duration
`of hypo-
`tension
`
`Temp.
`in F.
`
`Skin
`appearance
`
`Outcome
`
`Postoperative
`cholecystectomy,
`diabetes mellitus
`
`E. colt’
`
`Blood
`
`66/30
`
`24 hrs.
`
`102.0
`
`Cold, moist
`
`Died
`
`Urethral stricture
`
`E. coli
`
`Postoperative
`cancer of stomach
`
`Pseudomonas
`aeruginosa
`
`Urine
`Blood
`
`ne
`
`Uri
`Sputum
`
`78/50
`
`24 hrs.
`
`101.0 Warm,
`sufl'used
`
`Recovered
`
`80/54
`
`24 hrs.
`
`103.0 Warm,
`sufiused
`
`Recovered
`
`tensive for an average of 23 hours, the patients
`who succumbed were hypotensive for an average
`of six to seven days. Pressor substances were
`used to maintain blood pressure during the hy-
`potensive period and all patients were considered
`to be hypotensive until they no longer required
`pressor substances for the maintenance of blood
`pressure.
`
`were most frequently isolated. The severity of
`the underlying infectious process is emphasized
`by the fact that staphylococci were isolated from
`the blood in 50 per cent of those who died. Nine
`autopsies were performed in the series and no
`adrenal pathological change could be demon-
`strated, except in one patient, who had a hema-
`toma of a single adrenal. A characteristic dif-
`ference in the appearance of those who died from
`those who recovered was
`recorded frequently
`enough to note. The patients who succumbed
`The results of this study are given in Table II.
`displayed more often an ashen gray, cold, moist
`In the healthy subjects the concentrations of
`skin with mottling and cyanosis such as is en-
`plasma cortisol averaged 13 pg. per 100 ml., with
`countered in severe hemorrhagic shock.
`The
`a range of from 7 to 22 pg. per 100 ml.
`In this
`survivors had suffused, warm skin and a full pulse
`control group, all samples were obtained at 8:00
`in the presence of hypotension. The dichotomy
`am. The mean plasma cortisol concentrations of
`in the clinical picture of shock has been re-
`patients with shock due to infection was 63 pg.
`ported by Waisbren (13)
`and by Hall and
`per 100 ml., ranging from 30 to 160 pg. per 100
`Gold (14). The two groups differed significantly
`ml.
`The mean plasma cortisol concentration
`in the period of time they remained hypotensive.
`for the patients in shock was initially higher than
`Whereas the patients who recovered were hypo-
`TABLE II
`
`B. Concentration of cortisol in the plasma
`
`Concentration of cortisol in the plasma
`
`Patients with shock due to infection
`
`Survivors
`
`29
`
`Age
`
`Sex
`
`pg./100 ml.
`
`Fatalities
`
`No.
`
`Age
`
`Sex pg./I00 ml.
`
`28
`70
`64
`54
`60
`38
`S2
`79
`
`0O\lO\UInk<»N_r-
`
`47
`40
`49
`S3
`41
`43
`40
`78
`
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`
`58
`72
`60
`84
`73
`48
`85
`62
`53
`62
`67
`72
`
`30
`82
`69
`120
`61
`160
`72
`45
`68 -
`36
`54
`74
`
`Mean = 50 :1: 12
`Range = 40-78
`
`Mean = 73 :l: 34
`Range = 30-160
`
`2.°
`
`Normal subjects
`Age
`Sex
`pg./I00 ml.
`
`24
`23
`23
`19
`37
`22
`23
`31
`42
`
`§§E§""""§EE
`
`\OOO\lO\UlI5C»Is.)r-
`
`11
`12
`9
`22
`10
`16
`7
`17
`11
`
`Mean = 13 :l: 4-‘
`Range = 7-22
`
`* Standard deviation.
`
`

`
`1794
`
`JAMES C. MELBY AND WESLEY W. SPINK
`
`the mean plasma cortisol concentration in normals
`after a four hour infusion of corticotropin.
`In
`only one patient with shock was
`the plasma
`cortisol
`level within the normal
`range as ob-
`tained in this laboratory. The highest concentra-
`tions were found in the moribund patients.
`
`C. Effect of an intravenous infusion of cortico-
`tropin on plasma cortisol concentrations
`
`The results for normal subjects and for pa-
`tients are summarized in Tables III and IV.
`
`Four hour intravenous corticotropin tests were
`performed in eight normal
`individuals.
`The
`mean control value for cortisol was 15 pg. per 100
`ml. of plasma, with a range of 5 to 24 pg. per
`cent. Following the infusion of corticotropin, the
`concentrations rose to a range of 32 to 63 pg. per
`cent with a mean of 46 pg. per cent. Rarely
`have values exceeded 65 pg. per cent in normal
`subjects after corticotropin. Four hour cortico-
`tropin tests were carried out in six patients with
`shock. The initial plasma cortisol levels averaged
`53 pg. per 100 ml. and ranged from 36 to 76
`pg. per 100 ml. After a four hour infusion of
`corticotropin the cortisol
`levels rose to an aver-
`age level of 100 pg. per 100 ml. of plasma, with
`a range of 81 to 119 pg. per 100 ml. Three of
`the patients given corticotropin, all of whom died
`(Nos. 18, 19 and 20), had average postcortico-
`tropin infusion levels of 112 pg. per 100 ml. of
`plasma, whereas the mean value in three patients
`who recovered was 88 pg. per 100 ml. Sand-
`
`TABLE III
`
`Eflecl of corticotropin (25 U.S.P. units intravenously over a
`four hour period) on plasma cortisol concen-
`trations in normal subjects
`
`Plasma cortisol (pg./100 ml.)
`After
`Before
`cortico-
`cortico-
`tropin
`tropin
`
`16
`5
`19
`15
`10
`24
`14
`21
`
`52
`32
`40
`63
`33
`44
`51
`52
`
`O0\lO\<IIn-FOJIQI-d
`
`Mean = lS:I:6* Mean = 46:l:10
`Range = 5-24
`Range = 32-63
`
`* Standard deviation.
`
`TABLE IV
`
`Efiect of corticotropin (25 U.S.P. units intravenously over a
`four hour period) on plasma cortisol concentrations
`in patients with shock due to infection
`
`Patient
`no.
`
`Age Sex
`
`Outcome
`
`18
`20
`19
`3
`21
`22
`
`62 F
`72
`67 M
`64 M
`86 M
`75 M
`
`Died
`Died
`Died
`Recovered
`Recovered
`Recovered
`
`Plasma cortisol (pg./I00 ml.)
`Before
`After
`conica-
`cortico-
`tropin
`tropin
`
`36
`76
`5 1
`57
`45
`57
`
`1 19
`104
`l 14
`81
`96
`86
`
`Mean = 53 Mean = 100
`Range = 36- Range = 81-
`76
`119
`
`berg, Eik-Nes, Migeon and Samuels (15) have
`reported similar values in agonal patients.
`In
`their study the injection of cortisol—4—C“ into
`dying patients resulted in a reduced urinary ex-
`cretion of radioactive metabolites when compared
`with the normal. They concluded that the high
`levels of plasma cortisol that they obtained were
`due to impaired metabolism in the presence of
`normally functioning adrenals. Urinary 17-hy-
`droxycorticosteroid determinations were not made
`in the patients reported in this study because
`nearly all of the patients were oliguric and some
`rapidly developed azotemia. Under usual circum-
`stances the excretion of urinary l7-hydroxycorti—
`costeroids is a valuable index of cortisol produc-
`tion. But in shock, where there exists a reduc-
`
`tion in urinary output coupled with retention of
`conjugated cortisol metabolites
`in the plasma,
`the results would be unreliable (16).
`
`D. The rate of disappearance of infused cortisol
`sodium succinate from the plasma
`
`Levels of plasma cortisol following the rapid
`infusion of 100 mg. of cortisol sodium succinate
`are shown in Figure 1.
`It is to be recalled that
`the mean initial plasma concentrations of cortisol
`in the patients who recovered and in those who
`died were significantly elevated compared to the
`values found in the normal subjects. However,
`in the patients who died,
`the initial levels were
`higher than those in the patients who survived.
`Levels of cortisol in the plasma after the infusion
`of cortisol sodium succinate are plotted on semi-
`logarithmic paper at various time intervals. The
`
`

`
`ADRENAL FUNCTION IN SHOCK DUE TO INFECTION
`
`0 Control (8)
`0 Died (12)
`e Recovered (8)
`
`initial preinfusion or endogenous values are not
`subtracted from the
`subsequent
`postinfusion
`levels.
`It should be noted that in the patients
`who survived most of
`the postinfusion plasma
`cortisol concentrations were less than the initial
`
`Scheuer
`concentration of endogenous cortisol.
`and Bondy (17) demonstrated in healthy sub-
`jects that plasma cortisol concentrations were
`lower
`than endogenous preinjection concentra-
`tions at five to seven hours after the injection of
`100 mg. of cortisol-free alcohol.
`It cannot be
`assumed that the basal plasma levels of cortisol
`remain constant after an infusion of cortisol
`in
`
`in the light of consider-
`the “stressed” subject
`able experimental evidence.
`Sydnor
`(18) has
`shown that
`the intravenous administration of
`
`cortisol to bilaterally adrenalectomized “stressed”
`rats efiectively inhibits corticotropin secretion.
`Brodish and Long (19)
`in similar experiments
`found that complete inhibition of corticotropin
`release is accomplished within 5 to 20 minutes fol-
`lowing the infusion of cortisol. Richards and
`Pruitt (20), using permanent adrenal vein can-
`nulas in dogs, suppressed maximal adrenal secre-
`tory acivity after the induction of respiratory aci-
`dosis and operative trauma by infusions of corti-
`sol. Thus, it would seem unjustified to subtract
`initial plasma cortisol values from postinfusion
`values in patients with shock.
`In Table V,
`the individual plasma biological
`TABLE V
`
`Biological half-time of plasma cortisol after the intravenous
`injection of 100 mg. of cortisol as the
`21-hemisuccinate
`
`Healthy adults
`Subject
`Ti
`no.
`(min.)
`
`110.0
`102.1
`78.9
`65.7
`112.5
`131.2
`70.0
`142.8
`
`®\IO\UIb§CNI\JI-
`
`Patients with shock due to infection
`Survivors
`Fatalities
`
`Patient
`no.
`
`T}
`(min.)
`
`Patient
`no.
`
`T}
`(min.)
`
`106.2
`79.5
`85.9
`87.1
`105.8
`80.6
`95.4
`120.0
`
`0O\IO\UIrkoaI\)I—A
`
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`
`169.1
`332.3
`566.1
`661.5
`300.0
`592.1
`360.8
`578.8
`1,020.3
`444.3
`420.0
`173.0
`
`Mean = 101.6
`Range = 65.7—
`142.8
`
`Mean = 95.1
`Range = 79.5——
`120.0
`
`Mean =468.2
`Range = 169.1-
`1,020.3
`
`
`
`
`
`
`
`(N O
`
`PLASMACORTISOL(pg./I00ml.) N0
`
`A O
`
`I00 mg. of cortisol (as the
`/ hernisuccinate)
`I.V.
`2|O
`90
`I50
`TIME IN MINUTES
`
`270
`
`FIG. 1. RATE or DISAPPEARANCE or CORTISOL (IN-
`JECTED As THE 21—HEMISUCCINATE)
`‘I-‘ROM PLASMA or
`PATIENTS WITH SHOCK DUE TO INFECTION
`
`half-times for cortisol were compared in healthy
`subjects, in patients who survived and in patients
`who died from shock due to severe infection.
`
`The mean biological half-time of cortisol in the
`normal subjects was found to be 101.6 minutes.
`In patients who recovered,
`this value was 95.1
`minutes and in those. who died, 468.2 minutes.
`The biological half-time of cortisol in the plasma
`is determined to a large extent by the functional
`integrity of the liver (16). Liver function tests
`were performed in six of the moribund patients.
`These were abnormal
`in all six patients tested.
`Liverfunction was assessed in four of the pa-
`tients who survived and was found to be normal
`
`four patients. The half-time values of
`in all
`plasma cortisol
`in the healthy subjects and in
`the patients who survived are not significantly
`difierent.
`
`DISCUSSION
`
`The most significant feature in this study is that
`patients with shock due to an infection did not
`exhibit evidence of adrenal
`insufficiency. High
`concentrations of cortisol were present
`in the
`plasma in all patients studied. Furthermore, even
`in agonal patients there was a continued response
`of the adrenals to stimulation with corticotropin.
`
`

`
`1796
`
`JAMES C. MELBY AND WESLEY W. SPINK
`
`in the plasma of
`The high levels of cortisol
`the patients who recovered would appear to be
`solely due to an acceleration of the rate of produc-
`tion of endogenous cortisol because the admin-
`istered cortisol disappeared from the plasma at a
`normal rate. On the other hand, the greater con-
`centration of cortisol in the plasma of moribund
`patients may be accounted for, in part, by factors
`retarding the removal of cortisol from the blood
`and by increased cortisol production. The rela-
`tive contribution of adrenal secretory activity to
`the high blood levels of cortisol could not be de-
`termined in the presence of impeded removal of
`injected cortisol from the plasma in the moribund
`patients. However, documented clinical and ex-
`perimental evidence indicates that adrenal secre-
`tion of cortisol may be supranormal under similar
`conditions, in that the blood cortisol and urinary
`17-hydroxycorticosteroid excretion were markedly
`elevated in patients dying of severe burns (21).
`Dogs subjected to hemorrhagic shock demon-
`strated a maximal secretion of cortisol (22). The
`shock induced in dogs by lethal
`injections of
`bacterial endotoxin is associated with high blood
`levels of cortisol and maximal secretion of corti-
`
`sol in the adrenal venous efiiuent (23).
`Factors influencing the slope of
`the plasma
`cortisol removal curves have been reviewed by
`Samuels, Brown, Eik-Nes, Tyler and Dominguez
`(16).
`If the curves plotted in Figure 1 are ex-
`trapolated to zero time it will be seen that the
`values obtained-for the survivors and fatalities are
`not
`significantly different.
`Samuels and co-
`workers (16) refer to this value as the “apparent
`distribution volume” of cortisol. Thus, it appears
`unlikely that changes in the volume distribution
`of cortisol account for the difference observed.
`
`function, hepatic
`Impairment of hepatocellular
`blood flow, renal function and thyroid function
`all operate to reduce the rate of metabolic disposal
`of cortisol. All patients studied who were mori-
`bund were either markedly oliguric or anuric.
`The patients who survived demonstrated less
`significant abnormalities of
`renal
`function,
`:'.e.,
`mild azotemia and transient oliguria.
`Among the patients who died of bacterial
`shock, significant abnormalities of liver function
`were demonstrated.
`In none of
`the survivors
`
`studied was hepatic function significantly dis-
`turbed.
`In human patients major surgical pro-
`
`cedures (24), agonal states (15), certain acute
`infectious diseases in childhood (25), myxedema
`(26) and liver disease (27) have been associated
`with reduced plasma
`cortisol
`removal
`rates.
`Tourniquet shock (28)
`retards the turnover of
`cortisol—4—C1‘ in the rat.
`In the dog lethal doses
`of endotoxin induce shock and slow the removal
`
`of injected cortisol from the plasma (23).
`Eik-Nes and Samuels (29) have roughly cor-
`related the severity of “stress” with the degree
`of impairment of cortisol removal from the plasma
`of the dog—the more severe or lethal the “stress,”
`the greater the reduction of the rate of removal of
`cortisol from the plasma. Our own studies con-
`firm this view (30).
`It should be pointed out
`that small doses of bacterial polysaccharide (0.1
`to 2.0 pg.) injected into the dog accelerate the
`removal of exogenous cortisol from the plasma,
`whereas larger doses have the opposite effect.
`These observations
`supplement
`the results of
`McDonald, Weise and Peterson (31) who in-
`jected a bacterial pyrogen (Piromen@)
`into hu-
`mans and noted a rise in plasma cortisol and an
`acceleration of the removal of exogenous cortisol
`from the plasma.
`Although several factors probably influence the
`removal
`rate of exogenous cortisol
`from the
`plasma,
`it is conceivable that one of the most
`important
`independent variables
`in this study
`was the size of the bacterial
`inoculum and the
`amount of endotoxin made available.
`
`Peterson, Pierce, Wyngaarden, Bunim and
`Brodie (32) have been unable to correlate the
`rate of disposal of cortisol or its analogs with
`its biological activity. Neither does cortisol ex-
`ert
`its biological effects as a by-product of its
`catabolism. Any speculation as to rate of “utili-
`zation” of cortisol
`is not
`relevant. The term
`
`“relative adrenal insufficiency” in vascular collapse
`due to infection is misleading because the con-
`centration of biologically active cortisol
`in the
`plasma is
`supraphysiologic. Daughaday (33)
`has demonstrated two protein binding systems
`for cortisol in the plasma. The first, a globulin,
`is saturated at plasma levels of between 15 and
`30 pg. per 100 ml. The second, albumin, binds
`cortisol more loosely and can accomodate high
`plasma concentrations of cortisol. This system
`is easily reversible and readily allows dissociation
`of cortisol so that it may traverse the capillary
`
`

`
`ADRENAL FUNCTION
`
`IN SHOCK DUE TO INFECTION
`
`1797
`
`measured in terms of change in plasma cortisol
`concentration. Third, the biological half—time of
`exogenous cortisol injected as thesuccinate ester
`in plasma was evaluated.
`2. All of the patients with shock had consider-
`ably higher basal concentrations of cortisol in the
`plasma than did the healthy subjects.
`.In six pa-
`tients with shock who were studied there was a
`
`response to corticotropin similar to that' obtained
`in the healthy adults. The biological half—time
`of exogenous cortisol was not different
`from
`healthy subjects in those patients with shock who
`survived, but in those patients having fatal shock
`the biological half—time was considerably more
`prolonged than that observed in healthy subjects.
`The significance of these differences is discussed.
`3. Accelerated adrenal secretory activity was
`demonstrated in those patients who survived.
`In
`moribund patients unequivocal proof for increased
`adrenal secretory activity could not be obtained.
`
`ACKNOWLEDGMENT
`
`We deeply appreciate the technical assistance of Mrs.
`Harriet A. Aaker.
`
`REFERENCES
`
`membranes and become directly available to the
`tissues. Thus, it is likely that when the globulin
`system is exceeded the excess of plasma cortisol
`is freely diffusible.
`In the present study it would
`appear
`that under normal conditions adequate
`amounts of diflusible cortisol were available to
`
`the tissues in all of the patients studied. But
`under the unphysiologic conditions of shock these
`hormonal concentrations are insufficient. Obser-
`
`vations on patients in shock and investigations in
`animals with endotoxin shock make it apparent
`that the necessary amount of exogenous cortisol
`or its synthetic analogs far exceeds that which
`can be produced by maximal endogenous secre-
`tory activity (5).
`The importance of the relationship between the
`plasma concentration of readily diffusible corti-
`sol and the degree of tissue injury has been demon-
`strated experimentally.
`These studies will be
`reported in detail elsewhere (34), but
`the es-
`sential data can be cited here. After dogs had
`been injected intravenously with endotoxin pre-
`pared from E. coli, there was a prompt rise in
`the plasma concentration of cortisol, and a rise
`in the level of serum glutamic oxaloacetic trans-
`aminase.
`It is generally assumed that elevations
`in serum transaminase are associated with cellular
`
`It was apparent that maximal endogen-
`injury.
`ous secretion of cortisol did not ‘prevent the rise
`in transaminase levels. However, when large
`doses of cortisol were administered to the dogs
`along with the endotoxin there was only a small
`rise in the levels of transaminase. These observa-
`
`tions suggest that the level of cortisol concentra-
`tions found within the physiological range are
`inadequate for protection against
`tissue injury.
`These observations support
`the concept
`that
`if
`cortisol
`is to be used as a therapeutic agent in
`fulminant sepsis with vascular collapse, its action
`and therefore its dose should be pharmacologic.
`In this context
`it does not represent “replace-
`ment” therapy.
`'
`
`SUM MARY
`
`1. Adrenal function was studied in 17 healthy
`adults and in 22 adult patients having shock due
`to infection. Three quantitative studies were
`employed. First, the basal plasma cortisol level
`was determined.
`Second,
`the response of
`the
`adrenal
`to stimulation with corticotropin was
`
`of
`
`suprarenal
`
`apoplexy.
`
`Case
`l. Waterhouse, R.
`Lancet 1911, 1, 577.
`2. Friderichsen, C. Nebennierenapoplexie bei kleinen
`Kindem.
`Jb. Kinderheilk. 1918, 87, 109.
`3. Keefer, C. S.
`Infections in Medical Uses of Corti-
`sone Including Hydrocortisone and Corticotropin,
`F. D. W. Lukens, Ed. New York, Blakiston, 1954,
`p. 401.
`‘
`. Kass, E. H., and Finland, M. Adrenocortical hor-
`mones and the management of
`infection. Ann.
`Rev. Med. 1957, 8, 1.
`. Spink, W. W. ACTH and adrenocorticosteroids as
`therapeutic adjuncts in infectious diseases. New
`Engl. J. Med. 1957, 257, 979 and 1031.
`. Melby, J. C., Egdahl, R. H., and Spink, W. W.
`Effect of brucella endotoxin on adrenocortical
`function in the dog. Fed. Proc. 1957, 16, 425.
`. Bush, I. E., and Sandberg, A. A. Adrenocortical
`hormones in human plasma.
`J. biol. Chem. 1953,
`205, 783.
`. Silber, R. H., and Porter, C. C. The determination
`of 17,2l-dihydroxy-20-ketosteroids
`in urine and
`plasma.
`J. biol. Chem. 1954, 210, 923.
`.Peterson, R. E., Karrer, A., and Guerra, S. L.
`Evaluation of Silber-Porter procedure for de-
`termination of plasma hydrocortisone. Analyt.
`Chem. 1957, 29, 144.
`
`

`
`1798
`
`JAMES C. MELBY AND WESLEY W. SPINK
`
`10.
`11.
`
`Silber, R. H. Personal communication.
`Christy, N. P., Gordon, W. E. L., Longson, D.,
`Wallace, E. Z., and Jailer, J. W. Some observa-
`tions upon adrenal cortical function during preg-
`nancy. Program of the Fortieth Annual Meeting
`of The Endocrine Society, June 19, 1958, San
`Francisco, Calif.
`. Madsen, J., Done, A. K., Ely, R. S., and Kelley, V. C.
`Evaluation of water soluble hemisuccinate esters
`
`of hydrocortisone and prednisolone: Plasma"17-
`hydroxycorticosteroid concentrations following in-
`travenous administration. A. M. A. J. Dis. Child.
`In press.
`. Waisbren, B. A. Bacteremia due to gram-negative
`bacilli other than Salmonella; clinical and‘thera-
`peutic study. A. M. A. Arch. intern. Med. 1951,
`88, 467.
`V
`. Hall, W. H., and Gold, D.
`Shock’ associated with
`bacteremia: Review of thirty-five cases. A. M. A.
`Arch. intern. Med. 1955, 96, 403.
`. Sandberg, A. A., Eik-Nes, K., Migeon, C. J., and
`Samuels, L. T. Metabolism of adrenal steroids in
`dying patients.
`J. clin. Endocr. 1956, 16, 1001.
`. Samuels, L. T., Brown, H., Eik-Nes, K., Tyler, F. H.,
`and Dominguez, O. V. Extra-adrenal factors af-
`fecting the levels of 17-hydroxycorticosteroids in
`plasma in Ciba Foundation Colloquia in Endo-
`crinology. Vol. XI. Hormones in Blood, G. E. W.
`Wolstenholme and E. C. P. Millar, Eds. Boston,
`Little, Brown and Co., 1957, pp. 208-230.
`. Scheuer, J., and Bondy, P. K. The effect of intra-
`venous cortisol
`injections on the plasma cortisol
`concentration in man.
`J. clin. Invest. 1957, 36, 67.
`. Sydnor, K. L. Blood ACTH in the stressed adrenal-
`ectomized rat after intravenous injection of hy-
`drocortisone. Endocrinology 1955, 56, 204.
`. Brodish, A., and Long, C. N. H. Mechanism of in-
`hibition of ACTH release by hydrocortisone.
`Program of the Fortieth Annual Meeting of The
`Endocrine Society, June 20, 1958, San Francisco,
`Calif.
`. Richards, J. B., and Pruitt, R. L. Hydroc-ortisone
`suppression of stress induced adrenal 17—hydroxy-
`corticosteroid secretion in dogs. Research Report.
`Project NM O0708l.22.13, Naval Medical Research
`Institute, 1956, vol. 14, p. 601.
`. Hume, D. M., Nelson, D. H., and Miller, D. W.
`Blood and urinary 17-hydroxycorticosteroids
`in
`patients with severe burns. Ann. Surg. 1956, 143,
`316.
`
`22. Hume, D. M., and Nelson, D. H. Adrenal cortical
`function in surgical
`shock in Surgical Forum,
`The American College of Surgeons (1954), Vol.
`V. Philadelphia, W. B. Saunders and Co., 1955,
`pp. 568-575.
`. Melby, J. C., DeWall, R. A., Storey, J. L., and Eg-
`dahl, R. H. The production and catabolism of cor-
`tisol
`in experimental endotoxin shock (abstract).
`J. clin. Invest. 1957, 36, 914.
`. Sandberg, A. A., Eik-Nes, K., Samuels, L. T., and
`Tyler, F. H. The effects of surgery on the blood
`levels and metabolism of 17-hydroxycorticosteroids
`in man.
`J. clin. Invest. 1954, 33, 1509.
`. Done, A. K., and Kelley, V. C. The half-life of
`exogenous adrenocorticosteroids in health and dis-
`ease. J. clin. Endocr. 1956, 16, 921.
`. Peterson, R. E., Wyngaarden, J. B., Guerra, S. L.,
`Brodie, B. B., and Bunim, J. J. The physiological
`disposition and metabolic fate of hydrocortisone in
`man.
`J. clin. Invest. 1955, 34, 1779.
`. Brown, H., Willardson, D. G., Samuels, L. T., and
`Tyler, F. H.
`17-Hydroxycorticosteroid metabo-
`lism in liver disease.
`J. clin. Invest. 1954, 33, 1524.
`. Firschein, H. E., DeVenuto, F., Fitch, W. M., Pearce,
`E. M., and Westphal, U. Distribution of.
`in-
`jected cortisol-4-C“ in normal and shocked rats.
`Endocrinology 1957, 60, 347.
`. Eik-Nes, K. B., and Samuels, L. T. Metabolism of
`cortisol
`in normal and “stressed” dogs.
`Endo-
`crinology l958, 63, 82.
`. Melby, J. C., and Spink, W. W. Unpublished ob-
`servations.
`
`. McDonald, R. K., Weise, V. K., and Peterson, R. E.
`Effect of aspirin and reserpine on adrenocortical
`response to Piromen in man.
`Proc. Soc. exp.
`Biol. (N. Y.) 1956, 93, 343.
`. Peterson, R. E., Pierce, C. E., Wyngaarden, J. B.,
`Bunim, J. J., and Brodie, B. The physiological
`disposition and metabolic fate of cortisone in man.
`J. clin. Invest. 1957, 36, 1301.
`. Daughaday, W. H. Binding of corticosteroids by
`plasma proteins.
`III. The binding of corticosteroid
`and related hormones by human plasma and plasma
`protein fractions as measured by equilibrium dialy-
`sis.
`J. clin. Invest. 1958, 37, 511.
`. Melby, J. C., Egdahl, R. H., and Spink, W. W.
`Cortisol suppression of endotoxin induced serum
`transaminase elevation.
`J. clin. Endocr.
`In press.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket